Zentalis Pharmaceuticals ^Investors

Zentalis Pharmaceuticals is an innovative biopharmaceutical company headquartered in New York, New York, founded in 2014 The company focuses on the development of novel therapies for cancer treatment, utilizing cutting-edge research and technology Zentalis has attracted significant investment, totaling approximately $190,000,000, to advance its pipeline of drug candidates With a commitment to improving patient outcomes, Zentalis is dedicated to transforming the landscape of oncology therapeutics The firm operates within a dynamic environment, leveraging collaborations and partnerships to enhance its research and development efforts